Definium Therapeutics, Inc.
- Stock
- Ticker DFTX
- ISIN CA24477V1058
- Nasdaq
- US listing in dollars
Performance, volatility and drawdowns of Definium Therapeutics, Inc. since 07/2022, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $85,879. Global equities (VT): $15,235.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −86.0% in 12/2022, measured from the peak in 08/2022. It took 41 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | -32 | -32 | -41 | -46 | -48 | -59 | -75 | -72 |
| Net income | -35 | -23 | -43 | -67 | -50 | -77 | -159 | -51 |
| Earnings per share | -0.42 | -0.35 | -0.50 | -0.78 | -0.50 | -0.71 | -1.44 | -0.46 |
| Balance sheet | ||||||||
| Total assets | 302 | 275 | 265 | 237 | 440 | 401 | 1,113 | 1,074 |
| Liabilities | 61 | 53 | 80 | 106 | 108 | 122 | 194 | 106 |
| Equity | 241 | 223 | 185 | 131 | 332 | 279 | 919 | 968 |
| Cash | 274 | 83 | 33 | 20 | 258 | 263 | 655 | 241 |
| Long-term debt | 22 | 22 | 41 | 40 | 41 | 41 | 36 | 37 |
| Cash flow | ||||||||
| Operating cash flow | -25 | -29 | -30 | -30 | -43 | -43 | -53 | -53 |
| Free cash flow | -25 | -29 | -30 | -30 | -43 | -43 | -53 | -53 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +92.4%, weakest 2023 at +66.4%. 3 of 3 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 9 Nov 2026 | −$0.46 |
| 6 Aug 2026 | −$1.44 |
| 7 May 2026 | −$0.71 |
| 26 Feb 2026 | −$0.50 |
| 6 Nov 2025 | −$0.78 |
| 31 Jul 2025 | −$0.50 |
| 8 May 2025 | −$0.35 |
| 6 Mar 2025 | −$0.42 |
| 7 Nov 2024 | −$0.27 |
| 13 Aug 2024 | −$0.26 |
| 8 May 2024 | −$1.14 |
| 28 Feb 2024 | −$0.59 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €3.5bn
- Market cap in trading currency
- $3.88bn
- Enterprise value
- $2.87bn
- P/E
- –
- P/S
- –
- P/B
- 4.01
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -4.9%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- –
- Net income
- −$337m
- Earnings per share
- −$3.11
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -61.4%
- Return on assets
- -31.4%
Balance sheet and cash flow
- Cash
- $1.05bn
- Cash per share
- $7.65
- Financial debt
- $36.7m
- Debt/equity %
- 4
- Current ratio
- 15.53
- Book value per share
- $7.07
- Operating cash flow
- −$191m
- Free cash flow
- −$191m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 137m
- Volume
- 3.23m
- Avg. volume 3 months
- 1.97m
- Relative volume
- 1.6
Price and technicals
- Price
- $28.34
- 1 day
- −3.9%
- 52-week high
- $48.45
- 52-week low
- $10.68
- Distance to 52-week high
- −41.5%
- Distance to 52-week low
- +165.4%
- Distance to 50-day line
- −19.4%
- Distance to 200-day line
- −7.8%
- RSI (14)
- 34
- Volatility 1M
- 73.2%
Performance
- 1 week
- −11.7%
- 1 month
- −21.3%
- 3 months
- −34.5%
- 6 months
- +26.0%
- YTD
- +111.7%
- 1 year
- +159.3%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has DFTX performed since 07/2022?
$10,000 grew to $29,814 by 20 Nov 2026, which is +28.5% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is DFTX?
Volatility was 92.3% per year, measured on monthly returns. The largest decline from a peak was −86.0%, with the low in 12/2022.
How does DFTX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +14.5% per year at 14.6% volatility, DFTX returned +28.5% at 92.3%. The correlation of monthly returns was 0.40; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.
Why does this page show a US listing?
The figures use the stock's listing traded in the US. On individual days its path differs slightly from the price on the home exchange.